The Carlyle Group
http://www.carlyle.com/The Carlyle Group is one of the world’s largest private equity firms. The firm has more than $81.1 billion under management with 60 funds across four investment disciplines: buyouts, venture & growth capital, real estate and leveraged finance. Carlyle focuses on sectors including: aerospace & defense, automotive & transportation, consumer & retail, energy & power, financial services, healthcare, industrial, infrastructure, real estate, technology & business services and telecommunications & media. Carlyle employs more than 575 investment professionals, and its portfolio companies employ more than 286,000 people worldwide. The firm is based in Washington DC and has over 1200 investors in 68 countries.
View Older Stories View More Recent Stories
-
Houlihan Lokey (HLI) to Acquire Waller Helms Advisors
-
Houlihan Lokey to Acquire Waller Helms Advisors
-
Wheels Up Experience (UP) Appoints Gregory Summe to its Board
-
Wheels Up Announces Gregory Summe to Join Board of Directors
-
Sedgwick expands global marine operations to support sector's changing needs
-
Form S-8 Carlyle Group Inc.
-
Form 10-Q Carlyle Group Inc. For: Jun 30
-
Sungage Financial Announces John King as Their New Chief Financial Officer
-
The Carlyle Group LP (CG) PT Raised to $42 at TD Cowen
-
JPMorgan Downgrades The Carlyle Group LP (CG) to Neutral
-
Form SC 13D/A QuidelOrtho Corp Filed by: Carlyle Group Inc.
-
Quantum Capital to buy Cogentrix for $3 billion in bets on rising US power demand
-
The Carlyle Group (CG) to Sell Cogentrix to Quantum Capital for $3B
-
Quantum Capital Group to Acquire Cogentrix from Carlyle for $3 Billion
-
The Carlyle Group (CG) Misses Q2 EPS by 6c
-
Carlyle Secured Lending (CGBD) Announces Merger with Carlyle Secured Lending III
-
Form 8-K Carlyle Group Inc. For: Aug 05
-
Carlyle Secured Lending, Inc. Announces Merger with Carlyle Secured Lending III
-
Carlyle Secured Lending, Inc. Announces Financial Results For Second Quarter Ended 2024, Declares Third Quarter 2024 Dividends of $0.47 Per Common Share and Announces Merger Agreement with Carlyle Sec
-
Carlyle Q2 profit misses, shares drop amid market sell-off
-
Form 4 Carlyle Group Inc. For: Aug 01 Filed by: Andrews Charles Elliott Jr.
-
Form 4 Carlyle Group Inc. For: Aug 01 Filed by: Ferguson Jeffrey W.
-
Moderna Reports Second Quarter 2024 Financial Results and Provides Business Updates
-
NYC Organization of Public Service Retirees Demands Accountability following New Bill for 9/11 Funding
-
Form SC 13D/A QuidelOrtho Corp Filed by: Carlyle Group Inc.
-
Piramal Pharma Solutions Achieves Revenue Threshold on Innovation Work
-
Financier and Philanthropist David Rubenstein to Headline SS&C Deliver 2024 Conference
-
Piramal Pharma Limited Announces Consolidated Results for Q1FY25
-
SS&C Technologies Releases Q2 2024 Earnings Results, Announces $1 Billion Common Stock Repurchase Program
-
Form SC 13D/A QuidelOrtho Corp Filed by: Carlyle Group Inc.
-
Carlyle Credit Income Fund Schedules Third Quarter 2024 Financial Results and Investor Conference Call
-
Climate Investing Veteran Kirk Hourdajian Joins Montauk Climate as Partner and Head of Venture
-
Medical supplier Medline said to explore IPO in 2025, Bloomberg News reports
-
Sciens Building Solutions Acquires San Diego-area’s Standard Electronics
-
Moderna (MRNA) Appoints David Rubenstein to its Board
-
Moderna (MRNA) Announces Resignations of Robert Langer and Stephen Berenson from Board
-
David Rubenstein Joins Moderna's Board of Directors
-
Sciens Building Solutions Acquires Another Southern California Company
-
Sedgwick Consumer Product Safety Pulse Report reveals essential insights on consumer recall behavior
-
Form SC 13D/A QuidelOrtho Corp Filed by: Carlyle Group Inc.
-
Form 4 Carlyle Group Inc. For: Jul 10 Filed by: Carlyle Group Management L.L.C.
-
Sciens Building Solutions Unveils Sciens Service Suite for Fire and Life Safety Management
-
Form SC 13G/A Complete Solaria, Inc. Filed by: Carlyle Group Inc.
-
Flashlight Capital Partners Calls for Tesla-like CEO Compensation at KT&G
-
The Carlyle Group LP (CG) PT Raised to $45 at Jefferies
-
Form SC 13D Cano Health, Inc. Filed by: Carlyle Group Inc.
-
The Carlyle Group LP (CG) PT Raised to $69 at Oppenheimer
-
Baxter stock pops on reports of Carlyle's potential buyout of its kidney care unit
-
Carlyle in talks to buy Baxter's kidney care unit, source says
-
The Carlyle Group (CG) in Talks to Buy Baxter’s (BAX) Vantive for $4B - WSJ


